SCHEMBL7184929

SCHEMBL7184929

CCOc1c(C=CC(=O)c2ccc(NC)cc2)cc(CC)c(O)c1CC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.42
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
ATM Q13315 1/20 0.41
DPP4 P27487 2/20 0.41
MAOB P27338 4/20 0.40
ABCG2 Q9UNQ0 1/20 0.40
CYP1A1 P04798 3/20 0.40
CYP1B1 Q16678 3/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2D6 P10635 2/20 0.40
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
PTGS1 P23219 1/20 0.39
MAOA P21397 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
CTSL P07711 1/20 0.38
CTSB P07858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7184924 1.00 PTPN1 (0.42) PTPN1LMNAMAPTSMN1; SMN2ATM
SCHEMBL7189556 0.92 DPP4 (0.42) PTPN1DPP4ABCG2CYP1A1CYP1B1
SCHEMBL7189560 0.92 DPP4 (0.42) PTPN1DPP4ABCG2CYP1A1CYP1B1
SCHEMBL7192221 0.90 PTPN1 (0.44) PTPN1LMNAMAPTSMN1; SMN2ATM
SCHEMBL7192224 0.90 PTPN1 (0.44) PTPN1LMNAMAPTSMN1; SMN2ATM
SCHEMBL7192082 0.89 ABCG2 (0.52) PTPN1LMNAMAPTSMN1; SMN2ATM
SCHEMBL7192084 0.89 ABCG2 (0.52) PTPN1LMNAMAPTSMN1; SMN2ATM
SCHEMBL7192507 0.89 PTPN1 (0.41) PTPN1LMNAMAPTSMN1; SMN2ATM
SCHEMBL7192502 0.89 PTPN1 (0.41) PTPN1LMNAMAPTSMN1; SMN2ATM
SCHEMBL7187659 0.88 PTPN1 (0.53) PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed